Leef Brands Inc.
Leef Brands Inc. ICNAF Peers
See (ICNAF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ICNAF | $0.06 | +0.00% | 0 | N/A | N/A | N/A |
| MKKGY | $26.33 | +0.69% | 56.8B | 17.71 | $1.49 | +1.90% |
| MKGAF | $129.74 | +0.96% | 56.4B | 17.41 | $7.45 | +1.93% |
| HLNCF | $5.19 | +1.17% | 46.7B | 24.69 | $0.21 | +1.18% |
| TKPHF | $28.35 | +0.00% | 44.6B | 61.63 | $0.46 | +4.69% |
| IPSEY | $29.05 | +0.00% | 38.4B | 23.62 | $1.23 | +0.89% |
| SDZNY | $54.10 | +0.78% | 23.3B | -2704.75 | -$0.02 | +1.25% |
| TEVJF | $17.80 | +0.00% | 20.4B | -15.48 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| SGIOF | $18.05 | +0.00% | 15.4B | 13.08 | $1.38 | +2.31% |
Stock Comparison
ICNAF vs MKKGY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, MKKGY has a market cap of 56.8B. Regarding current trading prices, ICNAF is priced at $0.06, while MKKGY trades at $26.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas MKKGY's P/E ratio is 17.71. In terms of profitability, ICNAF's ROE is N/A, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, ICNAF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs MKGAF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, MKGAF has a market cap of 56.4B. Regarding current trading prices, ICNAF is priced at $0.06, while MKGAF trades at $129.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas MKGAF's P/E ratio is 17.41. In terms of profitability, ICNAF's ROE is N/A, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, ICNAF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs HLNCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HLNCF has a market cap of 46.7B. Regarding current trading prices, ICNAF is priced at $0.06, while HLNCF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HLNCF's P/E ratio is 24.69. In terms of profitability, ICNAF's ROE is N/A, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, ICNAF is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs TKPHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, TKPHF has a market cap of 44.6B. Regarding current trading prices, ICNAF is priced at $0.06, while TKPHF trades at $28.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas TKPHF's P/E ratio is 61.63. In terms of profitability, ICNAF's ROE is N/A, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, ICNAF is less volatile compared to TKPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs IPSEY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, IPSEY has a market cap of 38.4B. Regarding current trading prices, ICNAF is priced at $0.06, while IPSEY trades at $29.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 23.62. In terms of profitability, ICNAF's ROE is N/A, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, ICNAF is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs SDZNY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SDZNY has a market cap of 23.3B. Regarding current trading prices, ICNAF is priced at $0.06, while SDZNY trades at $54.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SDZNY's P/E ratio is -2704.75. In terms of profitability, ICNAF's ROE is N/A, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, ICNAF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs TEVJF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, TEVJF has a market cap of 20.4B. Regarding current trading prices, ICNAF is priced at $0.06, while TEVJF trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas TEVJF's P/E ratio is -15.48. In terms of profitability, ICNAF's ROE is N/A, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, ICNAF is less volatile compared to TEVJF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs ESALY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, ICNAF is priced at $0.06, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas ESALY's P/E ratio is 20.54. In terms of profitability, ICNAF's ROE is N/A, compared to ESALY's ROE of +0.06%. Regarding short-term risk, ICNAF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs SGIOF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SGIOF has a market cap of 15.4B. Regarding current trading prices, ICNAF is priced at $0.06, while SGIOF trades at $18.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SGIOF's P/E ratio is 13.08. In terms of profitability, ICNAF's ROE is N/A, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, ICNAF is less volatile compared to SGIOF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs SGIOY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SGIOY has a market cap of 14.9B. Regarding current trading prices, ICNAF is priced at $0.06, while SGIOY trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SGIOY's P/E ratio is 12.68. In terms of profitability, ICNAF's ROE is N/A, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, ICNAF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs BIOVF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, BIOVF has a market cap of 10B. Regarding current trading prices, ICNAF is priced at $0.06, while BIOVF trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas BIOVF's P/E ratio is 24.38. In terms of profitability, ICNAF's ROE is N/A, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, ICNAF and BIOVF have similar daily volatility (0.00).
ICNAF vs IPSEF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, ICNAF is priced at $0.06, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas IPSEF's P/E ratio is 22.81. In terms of profitability, ICNAF's ROE is N/A, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, ICNAF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs ESALF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, ESALF has a market cap of 8.3B. Regarding current trading prices, ICNAF is priced at $0.06, while ESALF trades at $29.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas ESALF's P/E ratio is 26.17. In terms of profitability, ICNAF's ROE is N/A, compared to ESALF's ROE of +0.03%. Regarding short-term risk, ICNAF is less volatile compared to ESALF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs SFOSF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SFOSF has a market cap of 8.2B. Regarding current trading prices, ICNAF is priced at $0.06, while SFOSF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SFOSF's P/E ratio is 13.03. In terms of profitability, ICNAF's ROE is N/A, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, ICNAF is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs ESAIY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, ESAIY has a market cap of 7.9B. Regarding current trading prices, ICNAF is priced at $0.06, while ESAIY trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas ESAIY's P/E ratio is 25.08. In terms of profitability, ICNAF's ROE is N/A, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, ICNAF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs HKMPY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HKMPY has a market cap of 6.1B. Regarding current trading prices, ICNAF is priced at $0.06, while HKMPY trades at $55.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HKMPY's P/E ratio is 17.23. In terms of profitability, ICNAF's ROE is N/A, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, ICNAF and HKMPY have similar daily volatility (0.00).
ICNAF vs HKMPF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HKMPF has a market cap of 6.1B. Regarding current trading prices, ICNAF is priced at $0.06, while HKMPF trades at $27.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HKMPF's P/E ratio is 17.22. In terms of profitability, ICNAF's ROE is N/A, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, ICNAF is less volatile compared to HKMPF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs GZPHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, GZPHF has a market cap of 5.7B. Regarding current trading prices, ICNAF is priced at $0.06, while GZPHF trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas GZPHF's P/E ratio is 9.70. In terms of profitability, ICNAF's ROE is N/A, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, ICNAF and GZPHF have similar daily volatility (0.00).
ICNAF vs SGFEF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, ICNAF is priced at $0.06, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SGFEF's P/E ratio is 25.35. In terms of profitability, ICNAF's ROE is N/A, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, ICNAF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs WIBFF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, ICNAF is priced at $0.06, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, ICNAF's ROE is N/A, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, ICNAF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs HLBBF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HLBBF has a market cap of 4.2B. Regarding current trading prices, ICNAF is priced at $0.06, while HLBBF trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HLBBF's P/E ratio is 10.49. In terms of profitability, ICNAF's ROE is N/A, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, ICNAF is less volatile compared to HLBBF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs LVZPF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, LVZPF has a market cap of 3.7B. Regarding current trading prices, ICNAF is priced at $0.06, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, ICNAF's ROE is N/A, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, ICNAF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs HLUBF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HLUBF has a market cap of 3.6B. Regarding current trading prices, ICNAF is priced at $0.06, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HLUBF's P/E ratio is 7.25. In terms of profitability, ICNAF's ROE is N/A, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, ICNAF is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs ULIHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, ULIHF has a market cap of 3.4B. Regarding current trading prices, ICNAF is priced at $0.06, while ULIHF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas ULIHF's P/E ratio is 9.25. In terms of profitability, ICNAF's ROE is N/A, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, ICNAF and ULIHF have similar daily volatility (0.00).
ICNAF vs APNHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, ICNAF is priced at $0.06, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas APNHF's P/E ratio is 12.95. In terms of profitability, ICNAF's ROE is N/A, compared to APNHF's ROE of +0.04%. Regarding short-term risk, ICNAF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs INVVY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, ICNAF is priced at $0.06, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas INVVY's P/E ratio is -62.42. In terms of profitability, ICNAF's ROE is N/A, compared to INVVY's ROE of -0.01%. Regarding short-term risk, ICNAF and INVVY have similar daily volatility (0.00).
ICNAF vs HYPMY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HYPMY has a market cap of 3B. Regarding current trading prices, ICNAF is priced at $0.06, while HYPMY trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HYPMY's P/E ratio is 20.65. In terms of profitability, ICNAF's ROE is N/A, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, ICNAF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs APNHY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, APNHY has a market cap of 3B. Regarding current trading prices, ICNAF is priced at $0.06, while APNHY trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas APNHY's P/E ratio is 11.94. In terms of profitability, ICNAF's ROE is N/A, compared to APNHY's ROE of +0.05%. Regarding short-term risk, ICNAF and APNHY have similar daily volatility (0.00).
ICNAF vs IZQVF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, ICNAF is priced at $0.06, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, ICNAF's ROE is N/A, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, ICNAF and IZQVF have similar daily volatility (0.00).
ICNAF vs LBTSF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, ICNAF is priced at $0.06, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas LBTSF's P/E ratio is 222.67. In terms of profitability, ICNAF's ROE is N/A, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, ICNAF and LBTSF have similar daily volatility (0.00).
ICNAF vs HMDCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, ICNAF is priced at $0.06, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, ICNAF's ROE is N/A, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, ICNAF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs DNPUF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, DNPUF has a market cap of 2.6B. Regarding current trading prices, ICNAF is priced at $0.06, while DNPUF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas DNPUF's P/E ratio is 15.98. In terms of profitability, ICNAF's ROE is N/A, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, ICNAF and DNPUF have similar daily volatility (0.00).
ICNAF vs SMDPY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SMDPY has a market cap of 2.4B. Regarding current trading prices, ICNAF is priced at $0.06, while SMDPY trades at $6.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SMDPY's P/E ratio is 14.83. In terms of profitability, ICNAF's ROE is N/A, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, ICNAF is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs THCBF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, ICNAF is priced at $0.06, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas THCBF's P/E ratio is -0.10. In terms of profitability, ICNAF's ROE is N/A, compared to THCBF's ROE of +0.00%. Regarding short-term risk, ICNAF is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CHSYF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, ICNAF is priced at $0.06, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, ICNAF's ROE is N/A, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, ICNAF and CHSYF have similar daily volatility (0.00).
ICNAF vs DMPHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, ICNAF is priced at $0.06, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, ICNAF's ROE is N/A, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, ICNAF is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs HTSUF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, ICNAF is priced at $0.06, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HTSUF's P/E ratio is 14.19. In terms of profitability, ICNAF's ROE is N/A, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, ICNAF is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs LJUIF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, ICNAF is priced at $0.06, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, ICNAF's ROE is N/A, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, ICNAF and LJUIF have similar daily volatility (0.00).
ICNAF vs ARSUF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, ICNAF is priced at $0.06, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, ICNAF's ROE is N/A, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, ICNAF and ARSUF have similar daily volatility (0.00).
ICNAF vs TSMRF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, ICNAF is priced at $0.06, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas TSMRF's P/E ratio is 10.99. In terms of profitability, ICNAF's ROE is N/A, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, ICNAF and TSMRF have similar daily volatility (0.00).
ICNAF vs NPNKF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, ICNAF is priced at $0.06, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas NPNKF's P/E ratio is 7.66. In terms of profitability, ICNAF's ROE is N/A, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, ICNAF is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs YIHCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, YIHCF has a market cap of 1.6B. Regarding current trading prices, ICNAF is priced at $0.06, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, ICNAF's ROE is N/A, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, ICNAF and YIHCF have similar daily volatility (0.00).
ICNAF vs MITPF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, ICNAF is priced at $0.06, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas MITPF's P/E ratio is -10.81. In terms of profitability, ICNAF's ROE is N/A, compared to MITPF's ROE of +4.92%. Regarding short-term risk, ICNAF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CHIZF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CHIZF has a market cap of 1.6B. Regarding current trading prices, ICNAF is priced at $0.06, while CHIZF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CHIZF's P/E ratio is 15.63. In terms of profitability, ICNAF's ROE is N/A, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, ICNAF and CHIZF have similar daily volatility (0.00).
ICNAF vs KARBF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, ICNAF is priced at $0.06, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas KARBF's P/E ratio is 262.50. In terms of profitability, ICNAF's ROE is N/A, compared to KARBF's ROE of N/A. Regarding short-term risk, ICNAF and KARBF have similar daily volatility (0.00).
ICNAF vs SHEZF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SHEZF has a market cap of 1.5B. Regarding current trading prices, ICNAF is priced at $0.06, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, ICNAF's ROE is N/A, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, ICNAF is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs EVOTF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, ICNAF is priced at $0.06, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, ICNAF's ROE is N/A, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, ICNAF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs NPPNY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, ICNAF is priced at $0.06, while NPPNY trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas NPPNY's P/E ratio is 6.18. In terms of profitability, ICNAF's ROE is N/A, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, ICNAF and NPPNY have similar daily volatility (0.00).
ICNAF vs GTBIF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, GTBIF has a market cap of 1.2B. Regarding current trading prices, ICNAF is priced at $0.06, while GTBIF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas GTBIF's P/E ratio is 24.67. In terms of profitability, ICNAF's ROE is N/A, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, ICNAF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs KSPHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, KSPHF has a market cap of 1.2B. Regarding current trading prices, ICNAF is priced at $0.06, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas KSPHF's P/E ratio is 14.51. In terms of profitability, ICNAF's ROE is N/A, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, ICNAF is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs GNMLF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, ICNAF is priced at $0.06, while GNMLF trades at $1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas GNMLF's P/E ratio is 9.67. In terms of profitability, ICNAF's ROE is N/A, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, ICNAF and GNMLF have similar daily volatility (0.00).
ICNAF vs SWGHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, ICNAF is priced at $0.06, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SWGHF's P/E ratio is 15.78. In terms of profitability, ICNAF's ROE is N/A, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, ICNAF and SWGHF have similar daily volatility (0.00).
ICNAF vs KKPCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, ICNAF is priced at $0.06, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas KKPCF's P/E ratio is 11.15. In terms of profitability, ICNAF's ROE is N/A, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, ICNAF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CASBF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CASBF has a market cap of 985.3M. Regarding current trading prices, ICNAF is priced at $0.06, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CASBF's P/E ratio is -15.24. In terms of profitability, ICNAF's ROE is N/A, compared to CASBF's ROE of -0.14%. Regarding short-term risk, ICNAF is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs SHPHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, ICNAF is priced at $0.06, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, ICNAF's ROE is N/A, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, ICNAF is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs LVTTF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, LVTTF has a market cap of 894.1M. Regarding current trading prices, ICNAF is priced at $0.06, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, ICNAF's ROE is N/A, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, ICNAF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs EVRRF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, EVRRF has a market cap of 893.1M. Regarding current trading prices, ICNAF is priced at $0.06, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, ICNAF's ROE is N/A, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, ICNAF and EVRRF have similar daily volatility (0.00).
ICNAF vs BIOGY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, BIOGY has a market cap of 884.8M. Regarding current trading prices, ICNAF is priced at $0.06, while BIOGY trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas BIOGY's P/E ratio is 28.07. In terms of profitability, ICNAF's ROE is N/A, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, ICNAF is less volatile compared to BIOGY. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs NRXCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, NRXCF has a market cap of 846.4M. Regarding current trading prices, ICNAF is priced at $0.06, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, ICNAF's ROE is N/A, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, ICNAF and NRXCF have similar daily volatility (0.00).
ICNAF vs TWAPF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, ICNAF is priced at $0.06, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas TWAPF's P/E ratio is 6.37. In terms of profitability, ICNAF's ROE is N/A, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, ICNAF is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs ELTP Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, ELTP has a market cap of 774M. Regarding current trading prices, ICNAF is priced at $0.06, while ELTP trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas ELTP's P/E ratio is -36.22. In terms of profitability, ICNAF's ROE is N/A, compared to ELTP's ROE of -0.36%. Regarding short-term risk, ICNAF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CSWYF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, ICNAF is priced at $0.06, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, ICNAF's ROE is N/A, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, ICNAF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs NIKA Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, NIKA has a market cap of 708.2M. Regarding current trading prices, ICNAF is priced at $0.06, while NIKA trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas NIKA's P/E ratio is N/A. In terms of profitability, ICNAF's ROE is N/A, compared to NIKA's ROE of +0.39%. Regarding short-term risk, ICNAF and NIKA have similar daily volatility (0.00).
ICNAF vs TRXPF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, ICNAF is priced at $0.06, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, ICNAF's ROE is N/A, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, ICNAF and TRXPF have similar daily volatility (0.00).
ICNAF vs TCNNF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, TCNNF has a market cap of 677.1M. Regarding current trading prices, ICNAF is priced at $0.06, while TCNNF trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas TCNNF's P/E ratio is -4.49. In terms of profitability, ICNAF's ROE is N/A, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, ICNAF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs SWDCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SWDCF has a market cap of 655.3M. Regarding current trading prices, ICNAF is priced at $0.06, while SWDCF trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SWDCF's P/E ratio is 68.33. In terms of profitability, ICNAF's ROE is N/A, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, ICNAF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs TRSSF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, ICNAF is priced at $0.06, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, ICNAF's ROE is N/A, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, ICNAF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CURLF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CURLF has a market cap of 598.3M. Regarding current trading prices, ICNAF is priced at $0.06, while CURLF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CURLF's P/E ratio is -2.39. In terms of profitability, ICNAF's ROE is N/A, compared to CURLF's ROE of -0.25%. Regarding short-term risk, ICNAF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs PKBFF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, PKBFF has a market cap of 549.2M. Regarding current trading prices, ICNAF is priced at $0.06, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas PKBFF's P/E ratio is N/A. In terms of profitability, ICNAF's ROE is N/A, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, ICNAF and PKBFF have similar daily volatility (0.00).
ICNAF vs CCHWF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, ICNAF is priced at $0.06, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, ICNAF's ROE is N/A, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, ICNAF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs BOIRF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, ICNAF is priced at $0.06, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, ICNAF's ROE is N/A, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, ICNAF is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs PEXXF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, ICNAF is priced at $0.06, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, ICNAF's ROE is N/A, compared to PEXXF's ROE of N/A. Regarding short-term risk, ICNAF and PEXXF have similar daily volatility (0.00).
ICNAF vs KHTRF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, KHTRF has a market cap of 420.4M. Regarding current trading prices, ICNAF is priced at $0.06, while KHTRF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas KHTRF's P/E ratio is 60.29. In terms of profitability, ICNAF's ROE is N/A, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, ICNAF and KHTRF have similar daily volatility (0.00).
ICNAF vs AGYTF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, ICNAF is priced at $0.06, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, ICNAF's ROE is N/A, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, ICNAF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs HUMDF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, ICNAF is priced at $0.06, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, ICNAF's ROE is N/A, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, ICNAF and HUMDF have similar daily volatility (0.00).
ICNAF vs GLASF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, GLASF has a market cap of 402.4M. Regarding current trading prices, ICNAF is priced at $0.06, while GLASF trades at $5.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas GLASF's P/E ratio is -63.33. In terms of profitability, ICNAF's ROE is N/A, compared to GLASF's ROE of +0.00%. Regarding short-term risk, ICNAF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs AIHLF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, AIHLF has a market cap of 396.2M. Regarding current trading prices, ICNAF is priced at $0.06, while AIHLF trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas AIHLF's P/E ratio is 8.45. In terms of profitability, ICNAF's ROE is N/A, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, ICNAF and AIHLF have similar daily volatility (0.00).
ICNAF vs BHCCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, BHCCF has a market cap of 271.2M. Regarding current trading prices, ICNAF is priced at $0.06, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, ICNAF's ROE is N/A, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, ICNAF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CPHRF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CPHRF has a market cap of 236.8M. Regarding current trading prices, ICNAF is priced at $0.06, while CPHRF trades at $9.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CPHRF's P/E ratio is 25.67. In terms of profitability, ICNAF's ROE is N/A, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, ICNAF is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs PLNHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, ICNAF is priced at $0.06, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, ICNAF's ROE is N/A, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, ICNAF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs VRNOF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, VRNOF has a market cap of 176.3M. Regarding current trading prices, ICNAF is priced at $0.06, while VRNOF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas VRNOF's P/E ratio is -0.49. In terms of profitability, ICNAF's ROE is N/A, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, ICNAF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CRLBF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CRLBF has a market cap of 168.7M. Regarding current trading prices, ICNAF is priced at $0.06, while CRLBF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CRLBF's P/E ratio is -2.08. In terms of profitability, ICNAF's ROE is N/A, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, ICNAF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CBSTF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CBSTF has a market cap of 152.3M. Regarding current trading prices, ICNAF is priced at $0.06, while CBSTF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CBSTF's P/E ratio is -0.22. In terms of profitability, ICNAF's ROE is N/A, compared to CBSTF's ROE of +10.11%. Regarding short-term risk, ICNAF is less volatile compared to CBSTF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs PHCUF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, PHCUF has a market cap of 137.2M. Regarding current trading prices, ICNAF is priced at $0.06, while PHCUF trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas PHCUF's P/E ratio is 515.00. In terms of profitability, ICNAF's ROE is N/A, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, ICNAF and PHCUF have similar daily volatility (0.00).
ICNAF vs COPHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, ICNAF is priced at $0.06, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas COPHF's P/E ratio is -0.02. In terms of profitability, ICNAF's ROE is N/A, compared to COPHF's ROE of -5.75%. Regarding short-term risk, ICNAF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs STMH Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, STMH has a market cap of 126.2M. Regarding current trading prices, ICNAF is priced at $0.06, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas STMH's P/E ratio is N/A. In terms of profitability, ICNAF's ROE is N/A, compared to STMH's ROE of -2.75%. Regarding short-term risk, ICNAF is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs NWPN Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, ICNAF is priced at $0.06, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas NWPN's P/E ratio is -0.04. In terms of profitability, ICNAF's ROE is N/A, compared to NWPN's ROE of +0.13%. Regarding short-term risk, ICNAF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CHALF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CHALF has a market cap of 116.3M. Regarding current trading prices, ICNAF is priced at $0.06, while CHALF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CHALF's P/E ratio is N/A. In terms of profitability, ICNAF's ROE is N/A, compared to CHALF's ROE of +0.00%. Regarding short-term risk, ICNAF is less volatile compared to CHALF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs HLTRF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HLTRF has a market cap of 115.5M. Regarding current trading prices, ICNAF is priced at $0.06, while HLTRF trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HLTRF's P/E ratio is -6.42. In terms of profitability, ICNAF's ROE is N/A, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, ICNAF and HLTRF have similar daily volatility (0.00).
ICNAF vs LPCUF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, ICNAF is priced at $0.06, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, ICNAF's ROE is N/A, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, ICNAF is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CNVCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, ICNAF is priced at $0.06, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, ICNAF's ROE is N/A, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, ICNAF and CNVCF have similar daily volatility (0.00).
ICNAF vs BIOYF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, BIOYF has a market cap of 98.4M. Regarding current trading prices, ICNAF is priced at $0.06, while BIOYF trades at $8.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas BIOYF's P/E ratio is 17.50. In terms of profitability, ICNAF's ROE is N/A, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, ICNAF is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs GRUSF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, GRUSF has a market cap of 92.9M. Regarding current trading prices, ICNAF is priced at $0.06, while GRUSF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas GRUSF's P/E ratio is -7.50. In terms of profitability, ICNAF's ROE is N/A, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, ICNAF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs LOVFF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, LOVFF has a market cap of 91.1M. Regarding current trading prices, ICNAF is priced at $0.06, while LOVFF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas LOVFF's P/E ratio is 9.96. In terms of profitability, ICNAF's ROE is N/A, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, ICNAF is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs DUTV Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, DUTV has a market cap of 90.1M. Regarding current trading prices, ICNAF is priced at $0.06, while DUTV trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas DUTV's P/E ratio is N/A. In terms of profitability, ICNAF's ROE is N/A, compared to DUTV's ROE of +0.02%. Regarding short-term risk, ICNAF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CBWTF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CBWTF has a market cap of 88.7M. Regarding current trading prices, ICNAF is priced at $0.06, while CBWTF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CBWTF's P/E ratio is 3.37. In terms of profitability, ICNAF's ROE is N/A, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, ICNAF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs LRDSF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, LRDSF has a market cap of 84.2M. Regarding current trading prices, ICNAF is priced at $0.06, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, ICNAF's ROE is N/A, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, ICNAF is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs GBLP Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, GBLP has a market cap of 83M. Regarding current trading prices, ICNAF is priced at $0.06, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas GBLP's P/E ratio is -0.67. In terms of profitability, ICNAF's ROE is N/A, compared to GBLP's ROE of +0.31%. Regarding short-term risk, ICNAF and GBLP have similar daily volatility (0.00).
ICNAF vs MEDXF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, MEDXF has a market cap of 75.5M. Regarding current trading prices, ICNAF is priced at $0.06, while MEDXF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas MEDXF's P/E ratio is 29.25. In terms of profitability, ICNAF's ROE is N/A, compared to MEDXF's ROE of +0.11%. Regarding short-term risk, ICNAF is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.